• AIM: To identify the pathogenic genes in pterygium.
INTRODUCTION

P
terygium is a general ocular surface and degenerative disease characterized by conjunctival fibrovascular proliferation and invasion of the peripheral cornea. Pterygium is composed of the head that invades the cornea, the neck that includes the superficial limbus and the body that overlie the sclera [1] . Diverse biological pathways including increase of mitotic proteins and protein implicated in tissue invasion were remarkably affected in pterygium. Additionally, fibrosis, inflammation, angiogenesis, collagen deposition and extracellular matrix breakdown are associated with pterygium [2] . Pterygium is noted to be more prevalent than 20% of some populations and typically affects the younger population and can potentially lead to blindness [3] . Different processes have been reported as part of the pathology of pterygium, including cytokines, growth factors, viral infections, genetic predisposition, anti-apoptotic mechanisms, immunological mechanisms and extracellular matrix remodeling [4] . Up to now, the major treatment for pterygium is surgical removal. However, it recurs aggressively after surgical excision, and further treatment modalities are wide excision, adjunctive radiotherapy and antimitotic chemotherapy [5] .
Therefore, understanding the underlying molecular mechanism in pterygium is vital to design a strategy for the non-surgical therapy of pterygium and the prevention of disease recurrence after surgery [6] . Here, we obtained differentially expressed genes (DEGs) in pterygium. The functional annotation was performed to uncover the biological function of DEGs. The protein-protein interaction (PPI) network and transcription factors (TFs)-target gene regulatory network were constructed. The expression of candidate DEGs were validated by the quantitative real-time polymerase chain reaction (qRT-PCR). Our study was useful in identifying pathogenic genes in the diagnosis or therapy of pterygium.
SUBJECTS AND METHODS Ethical Approval
The study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee of the First Affiliated Hospital of Bengbu Medical College. Informed written consent was obtained from all participants, and research protocols were approved by the ethical committee of our hospital. .
Gene Expression Profiles
RESULTS
Differentially Expressed Genes Analysis and Functional
Analyses After chip data processing, a total of 557 genes (321 up-regulated and 236 down-regulated) were identified. Top 20 genes were listed in Table 2 . And the heat map of all DEGs was demonstrated in Figure 1 . To investigate the biological function of the identified DEGs in pterygium, all DEGs were performed to GO term and KEGG analyses. In top 15 GO term analyses, single-organism developmental process, movement of cell or subcellular component, localization of cell and cell motility were the significant enrichment in biological process ( Figure 2 ). Receptor binding, protein complex binding, cell (Figure 3) . Plasma membrane region, extracellular matrix component, condensed chromosome and chromosome, centromeric region were the most remarkably enrichment in cellular component (Figure 4) . Additionally, proximal tubule bicarbonate reclamation, protein digestion and absorption were the significant enrichment signal pathway, which was shown in Table 3 and Figure 5 , respectively.
Protein-Protein Intercation Network PPI network was built and visualized by Cytoscape, which was shown in Figure 6 . The network consisted of 163 nodes and 191 edges. The proteins with high degrees were fibronectin 1 (FN1, degree=23), replication protein A2 (RPA2, degree=18), WNT signaling pathway regulator (APC, degree=15), estrogen receptor 1 (ESR1, degree=13), karyopherin subunit beta 1 (KPNB1, degree=8), damage specific DNA binding protein 1 (DDB1, degree=7), neurofibromin 2 (NF2, degree=7), mitotic (Table 4) . 
Validation of Quantitative Real-time Polymerase Chain
Reaction The expression of DEGs was quantified by qRT-PCR in blood samples of eight pterygium patients and three normal conjunctiva tissues. Eight DEGs including keratin 6A (KRT6A), ATP binding cassette subfamily A member 1 (ABCA1), mesenchyme homeobox 1 (MEOX1), protease, serine 23 (PRSS23), epithelial cell transforming 2 (ECT2), fibronectin 1 (FN1), matrix metallopeptidase (MMP3) and secreted protein acidic and cysteine rich (SPARC) were selected as candidate genes. As shown in Figure 8 , FN1 (P<0.05), PRSS23 (P<0.01), ABCA1 (P<0.05), KRT6A (P<0.05), ECT2 (P<0.05) and SPARC (P<0.01), were significantly up-regulated in the pterygium compared to those of normal controls; The expression level of MEOX1 and MMP3 had no significance between pterygium and normal controls, but had the upregulation tendency in pterygium. The expression pattern of all above DEGs was consistent with our integrated analysis. DISCUSSION It is significant to uncover the pathological mechanism of pterygium, which may provide a novel field in diagnosis and therapy of pterygium. In this study, we found several DEGs based on the GEO dataset, which was helpful in understanding the potential mechanism of pterygium and provide a new field in finding diagnosis biomarker and drug target of pterygium. FN1 was found with the highest degree in the PPI network of pterygium. It is one component of the extracellular matrix and is found up-regulated in whole retina of extensive nerve injury [8] . In addition, FN1 is increased in pterygia formation and recurrence [9] . Herein, we found up-regulated expression of FN1 in pterygium. And qRT-PCR also validated the upregulated tendency in pterygium. This suggested that the role of FN1 in the process of pterygium and might constitute promising new target for pterygium. KPNB1 is a differentially methylated gene in age-related macular degeneration [10] . In addition, the expression of KPNB1 is up-regulated in optic nerve heads with elevated-intraocular pressure-induced injury of glaucoma [11] . DDB1, also called XPE, plays a crucial role in nucleotide excision global genome repair pathway. Defect of DDB1 may be lead to pure xeroderma pigmentosum [12] . It is pointed out that patients with xeroderma pigmentosum are likely to develop ocular surface squamous neoplasia [12] . The inactivation of tumor-suppressor gene NF2 is related to the formation of retinal and optic nerve lesions in neurofibromatosis type 2 patients [13] , which is a clinically variable disease caused by NF2 gene mutations. Additionally, it is reported that NF2 is associated with dry eye disease [14] .
BUB3 is a human retinal endothelial protein identified by 2 or more peptides using multidimensional protein identification technology and plays a key role in the development of retinal [15] . Thus it can be seen that PNB1, DDB1, NF2 and BUB3 play a key role in the development of eye. Herein, we found that they were down-regulated in pterygium, which suggested the role in the process of pterygium. Further research is needed to validate their expression. PRSS23 is found differentially expressed in ipsilateral retinal ganglion cells [16] . Furthermore, the expression of PRSS23 is increased in the glaucomatous canine retina [17] . MEOX1
is implicated in differentiation of mesoderm [18] . In mice, homozygous mutation of MEOX1 gene has abnormalities in sclerotome and its derivatives [19] . Moreover, MEOX1 plays an essential function in maintaining of sclerotome polarity and axial skeleton formation [19] . ABCA1 is a cholesterol metabolic marker and mediates cholesterol efflux. The homozygous recessive mutation in the ABCA1 gene may be result in the accumulation of lipid and cholesterol in cornea and reticuloendothelial system [20] . ABCA1 is thought to play essential roles in degenerative retinal diseases [21] . Chen W and Neale BM et al identified ABCA1 as a risk factor for agerelated macular degeneration [22] . In addition, it is significantly up-regulated in pterygium [23] . KRT6A gene encodes for proteins implicated in wound healing. In a genome wide expression data, the expression of KRT6A is remarkably increased by at least 2-fold in pterygium [23] . In addition, Tong et al [23] found that KRT6A is significantly up-regulated in pterygium compared to conjunctiva in microarray analysis. In this study, we found that PRSS23, MEOX1, ABCA1 and KRT6A were all up-regulated in bioinformatics analysis and qRT-PCR validation. This suggested the association between PRSS23, MEOX1, ABCA1, KRT6A and pterygium and provided a new field for understanding the pathology mechanism of pterygium. It is reported that SSH1 plays a role in Wnt5a-enhanced migration in human corneal endothelial cells [24] . It has been demonstrated that RBM14 is down-regulated in primary visual cortex in dementia with lewy bodies [25] . UPK1B is an epithelial differentiation gene and functions in the cornea [26] . It is found up-regulated in the retinoblastoma tumors [27] . In this study, we found the down-regulated expression of SSH1 and RBM14 and up-regulated expression of UPK1B in pterygium. We speculated that SSH1, RBM14 and UPK1B played pivotal roles in the visual function of pterygium. ECT2 has been associated with tumor progression and is detected in a number of retinal progenitor cells [28] . Moreover, ECT2 is expressed in response to chemotherapy induced stress in the retinoblastoma therapy [29] . Additionally, ECT2 is overexpressed in the immortalized human corneal epithelial cell lines [30] . MMPs plays a crucial role in various eye diseases.
And disordered expression of MMPs in the eye has been involved in different disorders, such as pterygium [31] . MMP3, one member of MMPs, is an attractive candidate for the pathogenesis and development of pterygium. Seet et al [1] and Di Girolamo et al [31] found that MMP3 was up-regulated in pterygium. In addition, it is suggested that inhibitors of MMP3 have a protective role against extracellular matrix degradation, which is a manifestation of pterygium. In our study, we found that MMP3 was up-regulated in pterygium, which was in line with previous reports. This further indicated the role of MMP3 in the pathology process of pterygium. SPARC is a matrix protein that plays roles in various biological processes including epithelial-mesenchymal transition, tissue fibrosis and angiogenesis in primary pterygium [9] . Additionally, SPARC is a well-known mediator in collagen production and deposition [32] . It is reported that the expression of SPARC is related to aberrant extracellular matrix deposition in pterygium [1] . In this study, SPARC was up-regulated in pterygium, which was consistent with previous reports. This suggested that SPARC may be complicated in the pathogenesis of pterygium.
In addition, there was no study reported that the association of other five DEGs (RPA2, APC, ESR1, LRP5L and JOSD1) with eye disease, especially pterygium, their potential roles in pterygium needs further research. In summary, several DEGs including FN1, KPNB1, DDB1, NF2, BUB3, PRSS23, MEOX1, ABCA1, KRT6A, SSH1, RBM14 and UPK1B play a pivotal role in the pathology of pterygium. Our findings may contribute to the identification of early diagnosis biomarker or drug target for pterygium.
There are limitations to this study. Firstly, the intensive molecular function of above genes wasn't investigated in this study. The in vivo and in vitro experiments are necessary for exploring the molecular function of these genes in the process of pterygium in the future work. Secondly, the sample size for qRT-PCR validation was small, additional studies with larger cohorts of pterygium are needed to validate and demonstrate the expression pattern of identified genes.
